Objectives. This study sought to compare acute lumen changes and late lumen narrowing during and after excimer laser.assisted balloon angioplasty, measured by quantitative coronary angiography, with the immediate and long-term outcome of balloon angioplasty alone.
group of 106 successfully treated coronary lesions showed a similar immediate outcome but reduced long-term efficacy of excimer laser-assisted balloon angioplasty compared with that after balloon angioplasty alone.
(J Am Coil Cardiol 1995;26:939-46)
Currently, transluminal balloon angioplas~ (1) remains the most common applied technique for the percutaneous treatment of patients with coronary artery disease. In an attempt to improve primary success and to reduce acute complication and long-term restenosis rates associated with balloon coronary angioplasty, a variety of novel techniques and devices have been introduced over the past 10 years (2, 3) . Excimer laser coronary angioplasty removes atherosclerotic plaque by laser ablation, that is, vaporization of plaque tissue by short pulses of excimer laser radiation delivered through a fiberoptic cath-eter (4, 5) . Since the first patient with coronary artery disease was treated with a xenon chloride excimer laser in August 1988 (6) , excimer laser angioplasty has been increasingly used as an adjunct or alternative to balloon angioplasty (7) (8) (9) (10) (11) . Although laser angioplasty is followed by balloon dilation in more than 90% of cases ("to debulk and dilate"), it is hypothesized that reduction of atherosclerotic tissue mass by laser ablation with or without adjunctive balloon dilation may be more effective in enlarging the vessel lumen than balloon angioplasty alone. Data on thousands of patients undergoing excimer laser coronary angioplasty have now been accumulated in prospective, observational registries (10, 11 ). The reported primary success and complication rates of excimer laser angioplasty with or without adjunctive balloon dilation compared favorably with those of balloon angioplasty alone, specifically in complex coronary artery lesions (8) (9) (10) (11) (12) (13) (14) . However, comparative data on the immediate and long-term efficacy of excimer laser versus balloon coronary angioplasty are limited (8, 10) , and a reliable assessment of long-term results of excimer laser angioplasty is hampered by low angiographic follow-up rates in most published reports.
The aim of the present study was to compare the immediate and long-term efficacy of excimer laser versus balloon coronary angioplasty in matched patient groups with similar baseline stenosis characteristics and anginal patterns and complete late angiographic follow-up. In the past, this comparative approach of lesion matching has been satisfactorily applied by our group to compare the short-and long-term outcomes of directional atherectomy and balloon angioplasty (15) as well as stent implantation and balloon angioplasty as a surrogate for randomized trials (16) . Indeed, these matching studies have accurately predicted the angiographic outcomes of recently completed randomized investigations (17) (18) (19) (20) comparing these new interventional techniques with conventional balloon coronary angioplasty.
Methods

Patients.
For the purpose of the present study, a consecutive series of patients with native coronary artery lesions successfully treated by excimer laser-assisted balloon angioplasty was prospectively included. All patients had symptomatic coronary artery disease or objective evidence of myocardial ischemia, or both. A successful treatment was defined as procedural success (<50% residual diameter stenosis at the end of the intervention) without death, nonfatal myocardial infarction, bypass graft surgery or repeat angioplasty during the hospital period. Within the time frame of this study, 50 patients completed a 6-month follow-up period after a successful procedure for 56 coronary artery lesions. This patient cohort represents almost a fourth of the population treated with the excimer laser at our institution until now and reflects our experience with the device after completion of a learning curve. All patients except one (98% of eligible patients) underwent actual follow-up angiography an average (+SD) of 5.7 (_+ 1.5) months after intervention. Two patients successfully treated with excimer laser angioplasty for a chronic total coronary occlusion could not be satisfactorily matched with patients treated by balloon angioplasty according to the anglographic criteria described later. The study group, therefore, included 47 patients with 53 coronary artery lesions successfully treated by excimer laser-assisted balloon angioplasty who were individually matched with patients who had undergone successful conventional balloon coronary angioplasty. The clinical and angiographic details of the two treatment groups are described in Table 1 .
Laser procedure. The laser system consisted of a xenon chloride excimer laser (Advanced Interventional Systems, Inc.) emitting light pulses at a wavelength of 308 nm with a pulse duration of -200 ns and a repetition rate of 20 to 30 Hz. Over the wire laser catheters of 1.3-, 1.6-, and 2.0-mm diameter with a concentric multifiber arrangement around a central guide wire lumen were used. Laser ftuence at the catheter tip was set at levels ranging from 45 to 65 mJ/mm 2. For anticoagulation, aspirin and hcparin were given intravenously with additional doses of heparin as required to keep the activated clotting time >400 s for the duration of the procedure. The laser angioplasty procedure as performed in our institution has been described in detail previously (21) . If, after one pass with the laser catheter, the residual diameter stenosis was >50%, the lesion was passed with a larger diameter laser catheter, or adjunctive balloon dilation was performed. In three patients with three lesions, stand-alone laser angioplasty resulted in a satisfactory angiographic result. Before and after the laser procedure (and adjunctive balloon dilation), angiography was performed in multiple projections after intracoronary administration of nitroglycerin to control vasomotor tone. After intervention, the patients were monitored for 24 h, and 12-lead electrocardiograms were recorded and cardiac enzyme levels were measured twice a day. Six hours after the procedure, the sheaths were removed. After recanalization of a total or subtotal occlusion, a heparin infusion was maintained until the next morning; then, heparin was discontinued, and the sheaths removed. The only specific postprocedural drug regimen consisted of aspirin for 6 months. The patients were evaluated at the outpatient clinic at 1 and 6 months after the procedure or earlier if dictated by recurrence of symptoms. Late follow-up angiography was performed after intracoronary administration of nitroglycerin, replicating exactly the projections and settings used during the intervention.
October 1995:939- 46 OUTCOMES OF LASER AND BALLOON ANGIOPLASTY Quantitative coronary angiography. For each treated segment, the minimal lumen and reference diameters before and after the procedure and at follow-up angiography were derived from multiple matched projections. All cineangiograms were analyzed using the computer-based Cardiovascular Angiography Analysis System (CAAS), which has been described and validated previously (22) (23) (24) (25) . This system permits an objective and reproducible quantification of the minimal lumen diameter of a coronary segment in absolute millimeters. A computerderived estimation of the original arterial dimension at the site of obstruction (assuming there is no disease present) is used to define the interpolated reference diameter. The percent diameter and area stenosis as well as the cross-sectional area (in ram2), are then calculated. The length of the lesion (in mm) is determined from the diameter function on the basis of a curvature analysis. The area between the actual and reconstructed contours at the obstruction site is a measure of the amount of atherosclerotic plaque and is expressed in mm 2. Because the algorithm cannot measure total occlusions, a value of 0 mm was imputed for the minimal lumen diameter and a value of 100% for percent diameter stenosis. In these cases, the reference diameter after intervention was substituted for the reference diameter before intervention or at follow-up, respectively. To obtain the mean balloon diameter, the largest balloon at maximal inflation was measured in a nonforeshortened projection.
Matching process. To compare coronary lumen changes occurring during and after excimer laser-assisted balloon angioplasty with the short-and long-term changes during and after balloon angioplasty alone, a consecutive series of 53 lesions successfully treated by excimer laser (+balloon) angioplasty were matched with 53 successfully treated balloon angioplasty lesions. The coronary artery tree was subdivided into 15 segments according to the American Heart Association guidelines, and the lesions were individually matched according to preprocedural minimal lumen diameter, reference diameter and vessel location. The principles of matching by quantitative angiography arc as follows (15, 16, 26) : 1) The angiographic dimensions of matched lesions are assumed to be identical; and 2) the observed difference in minimal lumen and reference diameters between the two identical lesions must be within the range of reproducibility of the quantitative analysis system for lesion measurement (1 SD = 0.10 mm) (22) (23) (24) (25) . Thus, lesion pairs were selected in which the difference between these angiographic variables did not exceed 0.2 mm (twice the variability, 95% confidence limits). After completion of matching for these three angiographic variables, the patients' anginal status was introduced as an additional, clinical characteristic to enhance and refine the matching process. The data base from which the balloon angioplasty lesions were selected contains quantitative angiographic data on 3,736 coronary lesions treated by balloon angioplasty, enabling satisfactory matching of lesions and patients undergoing different interventions. Matching was performed by an independent unbiased physician (R.M.) without knowledge of procedural or clinical outcomes according to the aforementioned criteria.
Assessment of restenosis.
The following criteria were used to asses the long-term etficacy of excimer laser and balloon coronary angioplasty: 1) The primary angiographic variable of interest in this study representing the final angiographic outcome of either intervention was the minimal lumen diameter at follow-up. 2) The second criterion for restenosis chosen was ->50% diameter stenosis at follow-up, derived from the minimal lumen diameter and reference diameter of the vessel. This restenosis rate according to the categoric (dichotomous) approach was used because in clinical practice decision making is still based on this cutoff criterion, and it is the conventionally recognized angiographic definition of restenosis.
3) The third variable uses the gain in minimal lumen diameter achieved during an intervention and the subsequent lumen loss during follow-up related to the vessel size (reference diameter), enabling a comparison among vessels of different caliber (26) . The relative gain is calculated as (Postintervention minimal lumen diameter -Preintervention minimal lumen diameter)/ Reference diameter, and relative loss as (Postintervention minimal lumen diameter -Follow-up minimal lumen diameter)/Reference diameter. The relation between relative gain and relative loss was studied by means of regression analysis because there is experimental and clinical evidence of a proportional relation between the extent of vessel wall injury inflicted by an intervention (reflected angiographically as lumen gain) and the subsequent reparative response, that is, intimal hyperplasia (reflected angiographically as lumen loss) (15, 16, (26) (27) (28) (29) (30) (31) (32) . 4) The net gain in lumen improvement at follow-up normalized for vessel size is described by the net gain index: (Follow-up minimal lumen diameter -Preintervention minimal lumen diameter)/Reference diameter. 5) The loss index, as proposed by Kuntz et al. (33) and defined as late loss divided by acute gain, was calculated as (Postintervention minimal lumen diameter -Follow-up minimal lumen diameter)/ (Postintervention minimal lumen diameter -Preintervention minimal lumen diameter).
Statistical analysis. All values obtained from quantitative angiographic analysis and derived variables are expressed as mean value +_ SD. Differences between the two groups and within each group were assessed by two-factor repeatedmeasures analysis of variance. The Bonferroni correction was applied for multiple comparisons. Simple regression analysis was used to evaluate the relative gain/relative loss relation in each group. To compare the linear regressions for the two treatment groups, multiple regression analysis was performed introducing the type of intervention as a dummy variable. A p value <0.05 was considered to indicate a significant difference.
Results
Matching. Baseline clinical and quantitative angiographic characteristics of the two matched patient groups are presented in Table 1 . No significant differences in gender, age or anginal status were observed. Matching for angiographic variables was satisfactory with identical distribution of stenosis location and similar minimal lumen diameter and reference JACC Vol. 26 diameter measurements in both groups: 0.73 ± 0.47 and 2.71 ___ 0.42 mm for the laser angioplasty group and 0.74 z 0.46 and 2.72 +_ 0.41 mm for the balloon angioplasty group, respectively. The cumulative distribution curves for the minimal lumen diameter before either intervention ( Fig. 1) can be seen to overlap suitably. Other lesion variables (diameter stenosis, minimal lumen cross-sectional area, reference area, area stenosis, lesion length and plaque area) also did not differ significantly between groups. Qualitative descriptors of lesion morphology derived from visual analysis of coronary anglograms included the presence of a branch point in the stenotic segment (47% in the laser group vs. 49% in the balloon group), lesion calcification (23% vs. 13%, respectively) and relation of the lesion to a coronary bend (11% vs, 8%, respectively), which were not significantly different between groups. In both groups, 12 total occlusions were present before intervention (23% of total group). Thus, this matching technique resulted in the selection of two patient groups with similar clinical and preprocedural stenosis variables. Immediate results. The immediate outcome after excimer laser-assisted balloon angioplasty and balloon angioplasty alone as assessed by quantitative coronary angiography is shown in Figure 1 (top) and Tables 2 and 3 . The reference *p < 0.01 within groups, ?p < 0.05 interaction. F-up = at follow-up; Post = after intervention; Pre = before intervention; other abbreviations as in Table 1 , diameter did not change significantly after either intervention (from 2.71 ___ 0.42 to 2.84 _+ 0.49 mm in the laser angioplasty group vs. 2,72 +__ 0.41 to 2.69 ± 0.44 mm in the balloon angioplasty group). Both procedures resulted in a significant improvement in minimal lumen diameter; postprocedural minimal lumen diameter was 1.77 _ 0.41 mm in the laser group and 1.78 +_ 0.34 mm in the balloon-only group. Percent diameter stenosis after intervention was not different between groups (37 -+ 11% vs. 34 + 10%, respectively). Excirner laser angioplasty alone resulted in significant lesion debulking (minimal lumen diameter from 0,73 _+ 0.47 to 1.30 _+ 0.29 mm [p < 0.001]; 55% of acute gain in minimal lumen diameter in Figure 1 (bottom) and Tables 2  and 4 . The minimal lumen diameter at follow-up was significantly smaller after excimer laser-assisted balloon angioplasty than after balloon angioplasty alone (1.17 + 0.63 vs. 1.46 _+ 0.67 mm, respectively, p = 0.02), with consequently higher percent diameter stenosis (57 + 21% vs. 47 + 24%, respectively, p = 0.02) and lower net gain index (0.16 _+ 0.21 vs. 0.27 + 0.27, respectively, p = 0.02). Although relative lumen gain was equal in both treatment groups, relative lumen loss in the laser angioplasty group was almost twice as much as in the balloon angioplasty group (0.23 + 0.25 vs. 0.12 _+ 0.24, respectively, p = 0.01). Simple regression analysis demonstrated a linear relation between relative gain and relative loss for each treatment group (Fig. 2) , although the coefficient of correlation was comparatively low in both groups. The slope of the regression line was steeper in the excimer laser group (0.71) than in the balloon angioplasty group (0.30); this difference was of borderline statistical significance (p = 0.05). Loss index was greater in the laser angioplasty group than in the balloon angioplasty group (0.63 + 0.77 vs. 0.35 _+ 1.01, respectively), although this difference did not reach statistical significance (p = 0.10). According to the categoric approach, using the conventional 50% diameter stenosis cutoff criterion, the angiographic restenosis rate at follow-up was 57% after excimer laser-assisted balloon angioplasty and 34% after balloon angioplasty alone (p = 0.02).
Discussion
Matching studies. With the introduction of excimer laser angioplasty for the treatment of coronary artery disease (4) (5) (6) (7) (8) (9) (10) (11) , it was hoped that, besides improvement of acute success and complication rates (8) (9) (10) (11) (12) (13) (14) , the incidence of restenosis with this new intervention would be reduced in comparison with conventional balloon angioplasty. So far, direct comparisons of excimer laser versus balloon coronary angioplasty in the treatment of lesions with similar angiographic morphology are few (34) . Before the results of prospective, randomized trials became available, the comparative evaluation of matched coronary lesions undergoing different interventions was recognized as a valid method of comparing the short-and long-term efficacy of a new technique relative to conventional balloon angioplasty (15, 16, 26, 35) . In fact, the comparative quantitative angiographic analysis of matched lesions undergoing different interventions has accurately predicted the angiographic outcomes of subsequent randomized investigations of directional atherectomy (15, 17, 18) and coronary stenting (16, 19, 20) versus balloon angioplasty. Applying the same methodology of lesion matching presented an excellent opportunity to investigate the immediate and long-term results of excimer laser angioplasty compared with conventional balloon coronary angioplasty.
Immediate results. The immediate angiographic outcome of excimer laser-assisted balloon angioplasty was similar to that of conventional balloon angioplasty despite significant lesion debulking by excimer laser ablation, which accounted for 55% of the total gain in minimal lumen diameter in the laser-treated group. We recently demonstrated (21) that elastic recoil of the vessel wall after excimer laser-assisted balloon angioplasty is similar to that after balloon angioplasty alone using balloon catheters of equal size. The present findings may point toward, at least in part, a dilatory ("Dotter") effect of excimer laser angioplasty rather than effective debulking of plaque tissue as in directional atherectomy (15, 21, 26, 36) . Coaxial delivery of excimer laser pulses in arteries is accompanied by the generation of shock waves (37) and the repetitive formation and collapse of vapor bubbles causing explosive dilation and invagination of the adjacent arterial segment (38, 39) . Examination by intravascular angioscopy of the morphologic changes induced by pulsed excimer laser angioplasty in peripheral and coronary arteries (40) has revealed dissection flaps, fractures of plaques and abundant tissue remnants that corresponded to angiographic findings of haziness and dissections. Channels recanalized by multifiber laser catheters that emitted fluences of 40 to 60 m J/ram 2 were small and irregular, indicating insufficient tissue removal. In a recent quantitative angiographic study (41) , it was found that this may be largely a result of laser catheter undersizing rather than inefficient tissue removal by laser ablation. However, we complied with the general methodology not to use laser catheters with a diameter larger than two-thirds of the reference diameter of the vessel to reduce the risk of perforation, thereby limiting lumen gain by laser ablation. The procedural outcome of excimer laserassisted balloon angioplasty may, hence, largely be determined by the therapeutic effect of the "adjunctive" balloon dilation. The relative contribution of true debulking, that is, tissue removal by laser vaporization, and mere dilatory effects by excimer laser angioplasty in the recanalization of arterial obstructions remains to be determined.
Restenosis. Although acute lumen gain was similar in both treatment groups, the laser-treated group exhibited significantly greater lumen loss during follow-up, resulting in a significantly smaller minimal lumen diameter at follow-up. Why is there more restenosis after excimer laser angioplasty (7, 9, 10, 32) ? Two possible explanations may exist for this different behavior of the treated artery during follow-up:
1. In the achievement of a similar degree of acute lumen gain, excimer laser-assisted balloon angioplasty may inflict more damage to the vessel wall than balloon dilation alone. The intraluminal delivery of excimer laser pulses has been shown (38, 39) to induce extensive damage to the adjacent arterial wall, including medial necrosis, dissection planes filled with red blood cells and internal elastic lamina abrasion. Schwartz et al. (27, 28) have shown a strong relation between the extent of vessel wall injury during intervention and the degree of subsequent neointimal thickening in a swine model. Greater damage (injury) to the treated vessel segment would provoke a proportionally greater proliferative response (repair). Excimer laser angioplasty may give rise to a strong reparative, inflammatory reaction that would possibly not occur to that extent after the comparatively lesser trauma of balloon dilation. The more aggressive neointimal response may be appreciated angiographically as greater lumen loss at follow-up. A quantitative angiographic analysis of exeimer laser-assisted angioplasty of saphenous vein graft lesions suggested (42) that aggressive laser tissue debulking may adversely affect restenosis.
2. Excimer laser irradiation itself may inherently provoke a unique response of the vessel wall that precipitates more extensive neointimai hyperplasia. At the cellular level, the ultraviolet radiation from an excimer laser may be mutagenic (43) , promoting the proliferation and growth of smooth muscle cells and production of extracellular matrix.
Linear regression analysis has shown a correlation between relative gain at intervention (as an index of vessel wall injury) and relative loss during follow-up (as an index for neointimal hyperplasia) after balloon angioplasty (26, 44) , Wiktor stent implantation (30) , directional athereetomy (15, 31) and excimer laser-facilitated coronary angioplasty (32) . In our patients, a statistically significant, though somewhat weak, correlation was found between relative gain and relative loss in both treatment groups. More important, however, is the observation that the regression line is much steeper in the laser-treated group (slope 0.71 vs. 0.30; p --0.05). Also, the loss index (late loss divided by acute gain) was greater in the laser-treated group than in the balloon angioplasty group (0.63 vs. 0.35, p = 0.10). These findings imply a greater reactive response of the vessel wall after excimer laser-assisted balloon angioplasty than after conventional balloon angioplasty for any given level of lumen gain. These observations are in disagreement with the model for restenosis as proposed by Kuntz et al. (33) , which describes a uniform behavior of the vessel wall during follow-up, independent of the device used for intervention. Loss index in that model was consistently observed at 0.47 for balloon angioplasty, stenting or atherectomy. More recently, Bittl et al. (32) reported a loss index after excimer laser-facilitated coronary angioplasty of 0.58. Although of borderline statistical significance, the differential findings in the present study with respect to lumen renarrowing after intervention suggest that there may in fact be a device-specific influence on the neointimal response independent of lumen increase. Comparisons of late angiographic outcome in patients treated by coronary balloon angioplasty, stent implantation and directional atherectomy by our group have previously suggested the possibility of such a device-specific effect (45) (46) (47) .
Study limitations. The present study has several limitations:
1. It is an observational study in relatively small patient groups using a new interventional technique under continuous development. Future modifications in catheter design and treatment protocols may improve immediate and late results.
2. Because only successful procedures are compared, the present study does not give insight into the primary success rates of the two techniques. In observational registries, excimer laser angioplasty with or without adjunctive balloon dilation has been found to be associated with a higher primary success rate than balloon angioplasty alone, particularly in lesions with complex morphology (8) (9) (10) (11) (12) (13) (14) . Consequently, selection bias cannot be totally excluded. Although not statistically significant, there was a tendency toward treatment of somewhat longer lesions with the excimer laser than with balloon angioplasty. Longer lesions have been found to be independently associated with greater lumen loss during follow-up after coronary balloon angioplasty (29) but not after excimer laserfacilitated angioplasty (32).
3. Although the two groups are well matched for several angiographic variables and some patient characteristics (age, gender and angina class), procedure-related and other patient variables, such as diabetes or previous treatment at the lesion site, are not included in the analysis. However, in a previous matching study (15) Conclusions. In this study of matched coronary lesions, excimer laser angioplasty (with adjunctive balloon dilation in 94% of cases) achieved a similar immediate angiographic result as conventional balloon angioplasty but, as a result of more pronounced lumen renarrowing, was associated with a significantly less favorable long-term angiographic outcome.
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